Scientists have discovered a critical part of the body’s immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.
Professor Graham Lord, from The University of Manchester, led the study, which could translate into treatments for autoimmune diseases including Cancer, Diabetes, Multiple Sclerosis and Crohn’s Disease within a few years.
It is published in The Journal of Clinical Investigation today.
The discovery of the molecular pathway regulated by a tiny molecule – known as microRNA-142 – is a major advance in our understanding of the immune system.
The 10-year-study found that microRNA-142 controls Regulatory T cells, which modulate the immune system and prevent autoimmune disease. It is, they found, the most highly expressed regulator in the immune system.
Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering. But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit
Professor Graham Lord
And according to Professor Lord, the discovery could be translated into a viable drug treatment within a few years.
He said: “Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering.
“But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit.”
If the activity of Regulatory T cells is too low, this can cause other immune cells to attack our own body tissues. If these Regulatory T cells are too active, this leads to suppression of immune responses and can allow cancers to evade the immune system.
So being able to control them is a major step forward in our ability to control- and harness – the therapeutic power of the immune system.
Professor Richard Jenner from UCL, who led the computational side of the project, said that: “We were able to trace the molecular fingerprints of this molecule across other genes to determine how it acted as such a critical regulator.”
Professor Lord, now Vice President and Dean of the Faculty of Biology, Medicine and Health at The University of Manchester, added: “Scientists over the past decade or so have developed therapies which are able to modulate different pathways of the immune system. We hope that this new discovery will lead to the development of new ways to treat autoimmunity, infectious diseases and cancer and we are incredibly excited about where this may lead.”
The Latest on: Autoimmune diseases
[google_news title=”” keyword=”autoimmune diseases” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Autoimmune diseases
- New treatment could reverse hair loss caused by an autoimmune skin diseaseon May 9, 2024 at 1:21 pm
Researchers developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss. The microneedle patch delivers immune-regulating molecules that can teach T cells not ...
- New treatment could reverse hair loss caused by autoimmune skin disease alopecia areataon May 9, 2024 at 5:53 am
Researchers at MIT, Brigham and Women's Hospital, and Harvard Medical School have developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss and affects ...
- World Lupus Day 2024: Date, history, significance, facts about autoimmune diseaseon May 9, 2024 at 5:36 am
World Lupus Day is dedicated to people worldwide who suffer from this debilitating autoimmune disease and struggle with multiple symptoms across their body.
- World Lupus Day 2024: What to eat to keep chronic autoimmune disease under control?on May 9, 2024 at 5:32 am
Lupus is a common problem which occurs in every second person. Especially this disease is seen in women. For lupus patients, it is very important to pay attention to diet along with lifestyle.
- Why Obstetric History Matters When Assessing CV Risk in Women With Autoimmune Diseaseon May 9, 2024 at 3:26 am
A history of pregnancy complications can put women with autoimmune disease at a higher risk for CVD. Prophylaxis during pregnancy may avoid those complications in the first place.
- Protected: “Untold Stories” Podcast Shares Powerful Tales of Strength and Perseverance Amid Severe Autoimmune Conditionon May 7, 2024 at 6:01 am
People living with severe autoimmune disorders often feel unseen and unheard, either because others don’t understand their struggles or because they often appear “fine” to the outside world, whereas ...
- Briquilimab’s Market Potential and Competitive Advantage in Autoimmune Diseases: An Investment Opportunityon May 6, 2024 at 3:44 pm
Emily Bodnar’s rating is based on a thorough analysis of Jasper Therapeutics’ leading asset, briquilimab, and its potential in the market for autoimmune and inflammatory diseases. The favorable ...
- What is the association between cytokines and autoimmune diseases?on May 3, 2024 at 8:01 am
Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system homeostasis. When the immune system malfunctions, irregularities in cytokine ...
- Commentary: Why we don't hear more about autoimmunity diseases — Molly Murrayon April 29, 2024 at 10:20 pm
Autoimmune diseases cover more than 100 conditions — some with familiar names like lupus, multiple sclerosis, rheumatoid arthritis, psoriasis and diabetes.
- Bristol Myers pays $65M to expand Repertoire of autoimmune assetson April 29, 2024 at 3:15 am
Bristol Myers Squibb is placing a $65 million bet on Repertoire Immune Medicines’ approach to resetting the immune system. | Bristol Myers Squibb is placing a $65 million bet on Repertoire Immune ...
via Bing News